GSK

GSK NEWSROOM (405 press releases)

Advanced Filtering & Sorting Options:

GSK: NDA submission to US FDA for single-dose tafenoquine for the radical cure of Plasmodium vivax malaria

PRESS RELEASE -- 29, November 2017

Regulatory milestone affirms GSK’s strong commitment and scientific capabilities to fighting infectious diseases  LONDON/GENEVA, 29-Nov-2017 — /EuropaWire/ — GSK and Medicines for Malaria Venture (MMV) today announced the submission of a new drug application (NDA) by GSK to the United States … Read the full press release

GSK on UK Government’s Industrial Strategy: Meaningful targets, sustained efforts and coherent implementation will be critical to this strategy’s success

PRESS RELEASE -- 29, November 2017

LONDON, 29-Nov-2017 — /EuropaWire/ — Responding to the launch of the Industrial Strategy White Paper, published today by the UK Government, Phil Thomson, President, Global Affairs, at GSK said: “A new, long-term industrial strategy for the country is important and welcome. We … Read the full press release

ViiV Healthcare begins phase III study on long-acting two-drug regimen in virally suppressed adults with HIV-1 infection

PRESS RELEASE -- 29, November 2017

The ATLAS-2M study will evaluate injections every two months in virally suppressed patients LONDON, 29-Nov-2017 — /EuropaWire/ — Today (27 November 2017) ViiV Healthcare, the global specialist HIV company majority owned by GSK, with Pfizer Inc. and Shionogi Limited as shareholders, … Read the full press release

GSK: US FDA VRBPAC’s vote brings us one step closer to approval of Shingrix

PRESS RELEASE -- 14, September 2017

LONDON, 14-Sep-2017 — /EuropaWire/ — GlaxoSmithKline plc [LSE/NYSE: GSK] announced today that the Vaccines and Related Biological Products Advisory Committee (VRBPAC) of the US Food and Drug Administration (FDA) voted unanimously that the data support the efficacy and safety of Shingrix … Read the full press release

GSK: Benlysta plus standard of care prolonged control of disease activity in patients with active systemic lupus erythematosus (SLE)

PRESS RELEASE -- 19, June 2017

Final efficacy and safety results from phase II continuation study Madrid, Spain and London, UK, 19-Jun-2017 — /EuropaWire/ — GSK today announced results from a 10-year continuation study, which showed that Benlysta (belimumab) plus standard of care prolonged control of disease … Read the full press release

Relieve the Stress from Asthma Management with New MyAsthma App

PRESS RELEASE -- 18, April 2017

NOTTINGHAM, 18-Apr-2017 — /EuropaWire/ — A new and unique smartphone app to help people with asthma manage their condition has been developed by lung experts at the Nottingham Respiratory Research Unit and the pharmaceutical company GlaxoSmithKline (GSK). The MyAsthma app has been launched … Read the full press release

GSK will make change to its financial reporting from Q1 2017

PRESS RELEASE -- 12, April 2017

LONDON, 12-Apr-2017 — /EuropaWire/ — GSK keeps its financial reporting framework under regular review to ensure that it remains current and in line with both the latest regulatory requirements and developing best practice within the Pharmaceutical industry. As a result of … Read the full press release

UK government announces £100 million investment to develop new multi-disciplinary science and technology research centre

PRESS RELEASE -- 27, February 2017

SWINDON, 27-Feb-2017 — /EuropaWire/ — A major new £100 million investment by the government into the development of an innovative multi-disciplinary science and technology research centre was announced today (Thursday 23 February 2017) by Business Secretary Greg Clark. The new Rosalind … Read the full press release

WEF’s Global Gender Gap Report 2016: Prospects for Workplace Gender Equality Slip to 2186

PRESS RELEASE -- 28, October 2016

The World Economic Forum’s Global Gender Gap Report 2016 finds economic parity between the sexes could take 170 years after a dramatic slowdown in progress Slowdown partly down to chronic imbalances in salaries and labour force participation, despite the fact … Read the full press release

Sanofi welcomes Alan Main as EVP Consumer HealthCare

PRESS RELEASE -- 4, October 2016

PARIS, 04-Oct-2016 — /EuropaWire/ — Sanofi today announced the appointment of Alan Main as Executive Vice President Consumer HealthCare, effective October 1st, 2016. Mr. Main will be a member of the Executive Committee and lead a newly created Consumer Healthcare … Read the full press release

GlaxoSmithKline welcomes Brian McNamara as CEO of GSK’s Consumer Healthcare division

PRESS RELEASE -- 29, September 2016

LONDON, 29-Sep-2016 — /EuropaWire/ — GSK today announced that Brian McNamara, is appointed Chief Executive Officer (CEO) of GSK’s Consumer Healthcare division effective immediately. He succeeds Emma Walmsley who was last week appointed GSK CEO Designate succeeding Sir Andrew Witty as … Read the full press release